Evidence map›Paper›PMID 41896210›Full record

ArticleNature communications2026

Single-bacterial cell insights into mechanisms of ceftriaxone resistance in Neisseria subflava.

Xin Zhang, Hong Sheng Cheng, Xueliang Zhan, Xue Li, Jiamin Huang, Haoyu Liu, Damien Chua, Guoze Wang, Xingxing Li, Yue Shi and 9 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Xin Zhang *Department of Pharmacology, Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, School of Medicine, Southern University of Science and Technology, Shenzhen, China.ORCID http://orcid.org/0009-0001-2383-3115
Hong Sheng Cheng *Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.ORCID http://orcid.org/0000-0001-9745-7872
Xueliang Zhan *Department of Clinical Laboratory, Shenzhen Third People's Hospital, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China.
Xue Li *Pulmonary Disease Department III, Shenzhen Third People's Hospital, Shenzhen, China.
Jiamin HuangPulmonary Disease Department III, Shenzhen Third People's Hospital, Shenzhen, China.
Haoyu LiuDepartment of Pharmacology, Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, School of Medicine, Southern University of Science and Technology, Shenzhen, China.ORCID http://orcid.org/0009-0000-6280-9962
Damien ChuaLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.ORCID http://orcid.org/0000-0003-0007-1688
Guoze WangDepartment of Pharmacology, Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
Xingxing LiDepartment of Pharmacology, Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
Yue ShiDepartment of Pharmacology, Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
Fuxiang WangDepartment of Clinical Laboratory, Shenzhen Third People's Hospital, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China.
Zhe XuSenior Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
Jiuxin QuDepartment of Clinical Laboratory, Shenzhen Third People's Hospital, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China.
Kevin PetheLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.ORCID http://orcid.org/0000-0003-0916-8873
Guobao LiPulmonary Disease Department III, Shenzhen Third People's Hospital, Shenzhen, China.
Nguan Soon TanLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. nstan@ntu.edu.sg.ORCID http://orcid.org/0000-0003-0136-7341
Micheál Mac AogáinDepartment of Biochemistry, St. James's Hospital, Dublin, Ireland. m.macaogain@tcd.ie.ORCID http://orcid.org/0000-0002-1726-7700
Sanjay H ChotirmallLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. schotirmall@ntu.edu.sg.ORCID http://orcid.org/0000-0003-0417-7607
Liang LiDepartment of Pharmacology, Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, School of Medicine, Southern University of Science and Technology, Shenzhen, China. lil@sustech.edu.cn.ORCID http://orcid.org/0000-0003-1001-7837

Funding

National Natural Science Foundation of China (National Science Foundation of China) Grant No. 32470194
6 · The paper itself

Abstract

The contribution of airway pathobionts to chronic respiratory disease is increasingly recognized, yet the evolutionary processes that shift commensals to pathogens remain poorly understood. Here we investigate how antibiotic pressure drives adaptation in Neisseria subflava, a common airway commensal associated with bronchiectasis. Using serial passage under ceftriaxone exposure, we observe a >300-fold increase in resistance, accompanied by enhanced biofilm formation and genetic reprogramming. Whole-genome sequencing reveals recurrent mutations in the adhesin gene ataA, while single-cell transcriptomics identifies six functionally distinct clusters indicating adaptive programs in growth, metal homeostasis, oxidative stress, and cell-wall remodeling. Notably, biofilm integrity is maintained through compensatory upregulation of comP and bamE, which promotes phagocytic evasion and resistance in experimentally evolved strains and clinical isolates. Iron availability further stabilizes biofilm and modulates antibiotic tolerance, underscoring metal homeostasis as a contributory adaptive axis. Together, these findings reveal a multifaceted strategy by which N. subflava exploits antibiotic selection to transition towards pathogenicity. By integrating experimental evolution with single-cell resolution, we establish a framework for understanding the commensal-to-pathobiont transition, with broad implications for the airway microbiome and antimicrobial resistance in chronic respiratory disease.

Indexed as

Anti-Bacterial AgentsCeftriaxoneDrug Resistance, BacterialNeisseriaAdhesins, BacterialBiofilmsGene Expression Regulation, BacterialHumansIronMutationSingle-Cell AnalysisWhole Genome SequencingAdhesins, BacterialAnti-Bacterial AgentsCeftriaxoneIron

Identifiers

PMID41896210
PMCPMC13194663

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.